Protected Health Information: Has it been Compromised?

Ryan Whitney Managing Editor Loyola University Chicago School of Law, JD 2017   HIPAA breaches occur on a daily basis. Although undesirable, many of these breaches are not serious enough to require patient notification. But others are more egregious and can cause harm to both the patient and the providing entity. This article outlines a …
Read more

The Baxter Settlement and its Implications for FCA Liability

Kaitlin Lavin Executive Editor Loyola University Chicago School of Law, JD 2017   In January, Baxter Healthcare Corporation (“Baxter”) agreed to pay $18,158 million after the Department of Justice (DOJ) brought suit for violating the Food, Drug, and Cosmetic Act (FCDA) and the False Claims Act (FCA). The Baxter case is unique because it was …
Read more

New York Law Could Shake Up Compliance Departments

Gilbert Carrillo Executive Editor Loyola University Chicago School of Law, JD 2017   The state of New York is in the process of implementing a new rule requiring some financial U.S. and foreign institutions, with New York offices, to prove that their transaction monitoring and sanctions filtering programs for catching criminal activity do in fact …
Read more

Joint Guidance Confirms the Sharing of Health Information Subject to FTC Regulations, Not Only HIPAA

Logan Parker Privacy Editor Loyola University Chicago School of Law, LL.M. in Health Law 2017   On October 22, 2016, the Federal Trade Commission (“FTC”) in collaboration and conjunction with the Department of Health and Human Services’ Office for Civil Rights (“OCR”) released new guidance on key privacy and security considerations for organizations handling health …
Read more

Pharmaceutical Representatives in Chicago Soon to be Subject to Strict Licensing Requirements

Kimberly Seay Associate Editor Loyola University Chicago School of Law, J.D. 2018   On November 16, 2016, the City Council approved an ordinance amending Chicago Municipal Code § 4-6-010(c)(30), which will require the licensing of all pharmaceutical sales representatives in order to endorse pharmaceuticals within city limits and is set to take effect July 1, …
Read more

Compliance Spotlight: Ali Gross, UC Los Angeles Health

Alanna J. Kroeker Executive Editor Loyola University Chicago School of Law, JD 2017   Ali Gross is currently a Senior Privacy Analyst at University of California Los Angeles Health (UCLA).  Ms. Gross is a 2015 Loyola University Chicago School of Law Graduate where she also completed a health law certificate.  Ms. Gross knew she wanted …
Read more

Anticipating the Direction of SEC Compliance Issues Under President Trump’s Nominee for Chairman of the SEC, Jay Clayton.

Ed Tyrrell Associate Editor Loyola University Chicago School of Law, J.D. 2018   President Donald J. Trump wasted no time in nominating Jay Clayton, Partner at Sullivan Cromwell, as his pick for the chairman of the SEC. Clayton, a veteran Wall Street attorney, is renowned for his expertise in public and private mergers, acquisitions transactions, …
Read more

The SEC’s Whistleblower Program Proves Resilient Despite Adversity

Lauren Rushing Associate Editor Loyola University Chicago School of Law, J.D. 2018   In the span of one week, two financial services companies paid penalty fees to the Securities and Exchange Commission for intentionally undercutting the Whistleblower Program. Impeding whistleblower communication is averse to quashing misconduct in the marketplace, which is the program’s main goal. …
Read more

Olympic Compliance and the World Anti-Doping Agency

Morgan Slade Associate Editor Loyola University of Chicago School of Law, JD 2017   With the Olympics involving the participation of over two hundred member countries, the International Olympic Committee (IOC) regularly encounters issues with enforcing athlete anti- doping regulations. Due to repeated doping violations and cheating allegations, the need for a third party regulatory …
Read more